Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Norcliffe Capital investment portfolio
Norcliffe Capital has made numerous investments in companies such as Smi Drug Discovery, Afon Technology, and 4d Medicine within the Biotech sector.
vc
Portfolio
10
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (10)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| 4d Medicine Ltd 4D Medicine Ltd develops proprietary bio‑absorbable biomaterials and designs implantable medical devices for use in surgery, aiming to improve patient outcomes and serve the global medical‑device market. Its platform supports 3‑D‑printed implants and other surgical tools. | Healthcare & Life Sciences | Nottingham | Confirmed | 2025-09-30 |
| Afon Technology Ltd Afon Technology Ltd develops Glucowear™, a watch‑like, non‑invasive continuous blood‑glucose monitor that provides real‑time readings, targeting people with diabetes, those at risk of developing the condition, and non‑diabetic users seeking glucose monitoring. | Healthcare & Life Sciences | Caldicot | Confirmed | 2025-08-31 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (14)
Norcliffe Nominees Limited's positions across portfolio companies2026
- ORDINARY A1 3,507,120 → 4,057,666
- A1 4,117,740 → 0
- A1 SHARES 0 → 4,553,727
Articles (1)
- 30 Jul 2026